Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Immunity to influenza in man.

Couch RB, Kasel JA.

Annu Rev Microbiol. 1983;37:529-49. Review.

PMID:
6357060
2.

Immunity to influenza.

Schild GC, Oxford JS, Virelizier JL.

Dev Biol Stand. 1975;28:253-72.

PMID:
47824
3.

Defense mechanisms against influenza virus infection in the respiratory tract mucosa.

Tamura S, Kurata T.

Jpn J Infect Dis. 2004 Dec;57(6):236-47. Review.

4.

[Humoral and cellular immunity in influenza virus infection].

Werner GH.

Bull Acad Natl Med. 1993 Oct;177(7):1263-72; discussion 1272-3. French.

PMID:
8149262
5.

Antibody contributes to heterosubtypic protection against influenza A-induced tachypnea in cotton rats.

Straight TM, Ottolini MG, Prince GA, Eichelberger MC.

Virol J. 2008 Mar 20;5:44. doi: 10.1186/1743-422X-5-44.

6.

Recent zoonoses caused by influenza A viruses.

Alexander DJ, Brown IH.

Rev Sci Tech. 2000 Apr;19(1):197-225. Review.

PMID:
11189716
7.

The immune response to influenza vaccines.

Ghendon Y.

Acta Virol. 1990 May;34(3):295-304. Review.

PMID:
1980401
8.

Secretory immunity in influenza.

Shvartsman YS, Grigorieva SK.

J Infect Dis. 1979 Dec;140(6):837-43.

PMID:
541522
9.

Possible correlation between low antigenic drift of A(H1N1) influenza viruses and induction of HI antibodies.

Iorio AM, Zei T, Neri M, Alatri A.

Eur J Epidemiol. 1996 Dec;12(6):589-94.

PMID:
8982618
10.

Subtype cross-reactive, infection-enhancing antibody responses to influenza A viruses.

Tamura M, Webster RG, Ennis FA.

J Virol. 1994 Jun;68(6):3499-504.

11.

Effect of heterosubtypic immunity on infection with attenuated influenza A virus vaccines in young children.

Steinhoff MC, Fries LF, Karron RA, Clements ML, Murphy BR.

J Clin Microbiol. 1993 Apr;31(4):836-8.

12.

Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses.

Yoshida R, Igarashi M, Ozaki H, Kishida N, Tomabechi D, Kida H, Ito K, Takada A.

PLoS Pathog. 2009 Mar;5(3):e1000350. doi: 10.1371/journal.ppat.1000350. Epub 2009 Mar 20.

13.

Safety and immunogenicity of a recombinant protein influenza A vaccine in adult human volunteers and protective efficacy against wild-type H1N1 virus challenge.

Fries LF, Dillon SB, Hildreth JE, Karron RA, Funkhouser AW, Friedman CJ, Jones CS, Culleton VG, Clements ML.

J Infect Dis. 1993 Mar;167(3):593-601.

PMID:
8440931
14.
17.
18.

Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protection against influenza.

Tamura S, Funato H, Hirabayashi Y, Kikuta K, Suzuki Y, Nagamine T, Aizawa C, Nakagawa M, Kurata T.

Vaccine. 1990 Oct;8(5):479-85.

PMID:
2251874
19.
20.

A contribution of cellular immunity to protection against influenza in man.

Jennings R, Fenton RJ, McEntegart MG, Potter CW.

Med Microbiol Immunol. 1978 Nov 17;166(1-4):51-62.

PMID:
723791

Supplemental Content

Support Center